help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on June 26, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2756
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/9/3573    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wierup, N.
Right arrow Articles by Sjölund, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wierup, N.
Right arrow Articles by Sjölund, K.
Related Collections
Right arrow Obesity

Submitted on December 13, 2006
Accepted on June 18, 2007

Ghrelin and motilin are co-secreted from a prominent endocrine cell population in the small intestine

Nils Wierup*, Maria Björkqvist, Björn Weström, Stefan Pierzynowski, Frank Sundler, and Kristina Sjölund

Department of Experimental Medical Science, Lund University, Lund, Sweden; Department of Cell and Organism Biology, Lund University, Lund, Sweden; Department of Internal Medicine, Lund University Hospital, Sweden

* To whom correspondence should be addressed. E-mail: nils.wierup{at}med.lu.se.

Context: Ghrelin is a novel hormone produced mainly in the gastric body. Hitherto, mapping studies of ghrelin cells covering the entire GI-tract in humans have been lacking. Further, the phenotype of extragastric ghrelin cells is not known.

Objective: To perform a detailed mapping with specimens from all parts of the GI-tract, and co-localisation studies to phenotype ghrelin cells along the tract. In addition, mapping of ghrelin cells was performed in porcine GI-tract, and the plasma profiles of ghrelin and motilin in blood from the porcine intestine were measured.

Design: Biopsies from patients were obtained during gastroscopy or surgery. Ghrelin cell density and phenotyping was assessed with immunocytochemistry, in situ hybridisation, and immunogold electron microscopy. Plasma ghrelin and motilin levels were measured in pigs, fitted with cannulas in the mesenteric vein.

Results: The upper small intestine is unexpectedly rich in ghrelin cells, and these cells contribute to circulating ghrelin. Ghrelin and motilin are co-produced in the same cells in the duodenum and jejunum of both species, and ghrelin and motilin are stored in all secretory granules of such cells in humans, indicating co-secretion. The plasma profiles of ghrelin and motilin in pig were parallel and a correlation between ghrelin and motilin (r2=0.22; p<0.001) was evident in intestinal blood.

Conclusions: The upper small intestine is an important source of ghrelin. The likely co-secretion of intestinal ghrelin and motilin suggests concerted actions of the two hormones. These data may have implications for understanding gut motility and clinical implications for dysmotility and bariatric surgery.


Key words: ghrelin • motilin • human • porcine • gastro-intestinal tract • gut hormones • co-localisation • co-secretion







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society